DSIP 15mg

DSIP 15mg is a synthetic peptide supplied as a lyophilised powder for laboratory research use. It is selected within controlled environments for investigation into peptide structure, neuropeptide interaction, and signalling pathways.

Classification: Delta Sleep-Inducing Peptide (DSIP) — a nine amino-acid neuropeptide (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) first isolated from rabbit cerebral venous blood in 1977.

Within laboratory settings, DSIP is studied for its interaction with neuroregulatory pathways and peptide signalling systems. Research applications focus on receptor activity, peptide stability, and central nervous system pathway modelling under controlled experimental conditions.

This summary describes published preclinical and, where applicable, clinical research. It is not a medical claim and does not describe or endorse any human use of the compound as sold by Peptides UK 4U.

Published preclinical research investigates DSIP as a modulator of slow-wave sleep architecture, hypothalamic-pituitary-adrenal (HPA) axis activity and stress-response signalling. Its precise receptor target has not been definitively characterised in the published literature; proposed mechanisms include interaction with GABAergic pathways and modulation of neurotransmitter release. All content is presented as research background, not established pharmacology.

This product is typically reconstituted using bacteriostatic water or a suitable sterile solvent within a controlled laboratory setting. All handling should be carried out by qualified professionals using appropriate sterile techniques and safety procedures.

Storage & stability

• Store in a cool, dry environment before reconstitution.
• For extended stability, storage at -20°C is recommended.
• Avoid repeated freeze-thaw cycles after reconstitution.

For reconstitution volumes and target working concentrations use our peptide calculator. We do not publish dosing protocols for human use.

Peptide Type

Neuropeptide analogue

Form

Lyophilised powder

Quantity

15mg

Purity

≥98% (subject to batch testing)

Appearance

White lyophilised powder

Solubility

Water soluble

Stability

Maintains integrity under controlled storage conditions

Manufacturing Standard

Produced in controlled laboratory environments

Certificate of Analysis: Available on request from our support team.

• Schoenenberger GA & Monnier M, PNAS 74(3):1282–1286 (1977) — isolation of DSIP
• Graf MV & Kastin AJ, Neuroscience & Biobehavioral Reviews 8(1):83–93 (1984) — DSIP review
• Kovalzon VM & Strekalova TV, Neuroscience & Behavioral Physiology 36(6):525–531 (2006) — DSIP and sleep

References are provided for educational context. Citation does not imply endorsement of any specific use.